A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population
- PMID: 21987612
- PMCID: PMC3180022
- DOI: 10.3748/wjg.v17.i31.3640
A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population
Abstract
Aim: To examine the determinants of maternal-neonatal transmission of hepatitis B virus (HBV).
Methods: A nested case-control study was conducted in Changsha, Hunan, People's Republic of China from January 1, 2005 to September 31, 2006. To avoid potential maternal blood contamination, we collected vein blood of newborns immediately after birth and before initial hepatitis B vaccination to determine the HBV infection status of the newborn. For each HBsAg-positive infant, one HBsAg-negative infant born to an HBsAg-positive mother was matched by hospital at birth (same), gender (same), and date of birth (within 1 mo). A face-to-face interview was conducted to collect clinical and epidemiological data. Conditional logistic regression analysis was used to estimate the independent effects of various determinants on maternal-neonatal transmission of HBV.
Results: A total of 141 HBsAg-positive infants and 141 individually matched HBsAg-negative infants were included in the final analysis. Maternal first-degree family history of HBV infection, intrahepatic cholestasis, and premature rupture of membranes were risk factors for perinatal transmission of HBV, whereas systematic treatment and HBV immunoglobulin injections for mothers with HBV infection were protective factors for maternal-neonatal transmission of HBV, after adjustment for potential confounding factors.
Conclusion: For HBsAg-positive mothers, systematic treatment, HBV immunoglobulin administration, and controlling intrahepatic cholestasis and pregnancy complications may reduce the incidence of perinatal transmission of HBV.
Keywords: HBsAg-positive; Hepatitis B virus; Perinatal transmission: Nested case-control study.
Similar articles
-
[Predictive study of HBsAg in different stages of neonatal venous blood on failure of blocking HBV mother to infant transmission].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):338-41. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 22338218 Chinese.
-
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.BMC Infect Dis. 2016 Aug 12;16(1):408. doi: 10.1186/s12879-016-1754-1. BMC Infect Dis. 2016. PMID: 27515176 Free PMC article.
-
[Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].Zhonghua Gan Zang Bing Za Zhi. 2013 Feb;21(2):105-10. doi: 10.3760/cma.j.issn.1007-3418.2013.02.008. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 23663881 Clinical Trial. Chinese.
-
#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.Am J Obstet Gynecol. 2016 Jan;214(1):6-14. doi: 10.1016/j.ajog.2015.09.100. Epub 2015 Oct 8. Am J Obstet Gynecol. 2016. PMID: 26454123 Review.
-
Eradicating hepatitis B virus: The critical role of preventing perinatal transmission.Biologicals. 2017 Nov;50:3-19. doi: 10.1016/j.biologicals.2017.08.008. Epub 2017 Sep 2. Biologicals. 2017. PMID: 28870397 Review.
Cited by
-
The impact of intrahepatic cholestasis of pregnancy with hepatitis B virus infection on perinatal outcomes.Ther Clin Risk Manag. 2014 May 23;10:381-5. doi: 10.2147/TCRM.S61530. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 24920912 Free PMC article.
-
Prevention of vertical transmission of hepatitis B virus infection.World J Gastroenterol. 2021 Jul 14;27(26):4182-4193. doi: 10.3748/wjg.v27.i26.4182. World J Gastroenterol. 2021. PMID: 34326618 Free PMC article. Review.
-
Vertical Transmission of Hepatitis B Virus-An Update.Microorganisms. 2023 Apr 27;11(5):1140. doi: 10.3390/microorganisms11051140. Microorganisms. 2023. PMID: 37317114 Free PMC article. Review.
-
Neonatal-perinatal medicine in a transitional period in China.Arch Dis Child Fetal Neonatal Ed. 2013 Sep;98(5):F440-4. doi: 10.1136/archdischild-2012-302524. Epub 2013 Jun 12. Arch Dis Child Fetal Neonatal Ed. 2013. PMID: 23759518 Free PMC article. Review.
-
Management of chronic hepatitis B in pregnancy.World J Gastroenterol. 2012 Sep 7;18(33):4517-21. doi: 10.3748/wjg.v18.i33.4517. World J Gastroenterol. 2012. PMID: 22969224 Free PMC article. Review.
References
-
- Zhang X, Wu J, Gao S. Research status about vertical transmission and prevention of HBV. Zhonghua Weichan Yixue Zazhi. 2002;5:231–232.
-
- Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect. 2009;58:383–388. - PubMed
-
- Zhang L, Yan BY, Li LM. [Prevalence, clinical and public health significance of occult hepatitis B virus infection] Zhonghua Liuxing Bingxue Zazhi. 2008;29:1149–1152. - PubMed
-
- Huang K, Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine. 2000;18 Suppl 1:S35–S38. - PubMed
-
- Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaecol Obstet. 2001;72:103–108. - PubMed